We recently conducted a podcast with ImmuneWatch, an innovative start-up in Dunden using machine learning to decode T-cell responses for diagnostics and therapeutics.
In this podcast series, CEOs Sander Wuyts (ImmuneWatch) and Vanessa Vankerckhoven (Idevax) shared their journeys from academia to entrepreneurship, both having launched their companies as university spin-offs. They discussed what motivated their transition—emphasizing collaboration and the drive to create real-world impact.
In the podcast, they also explored the future of healthcare, their long-term visions, and their passion for building something meaningful. The work of both companies overlaps in exciting ways, particularly in leveraging ImmuneWatch’s data modelling tools to improve T-cell response predictions for intradermal vaccination and drug delivery.
To wrap things up, the podcast ended with a fun question: Who is their favourite scientist? Any guesses? Find out in the full interview!
Want to know more? Watch the full podcast here
Interested in our solutions?
Contact our commercial team!